Today’s top gainers include the company Allergan plc (NYSE:AGN) which is in the industry Drugs – Generic, gaining 0.13% today. In the last week its performance is -0.83%, and 20.50% for the past quarter. Currently, Allergan plc, AGN has a target price of 291.44, so today’s gain of 0.13% is a significant step towards its target price. The GAP today is therefore 0.22%.
Allergan plc (NYSE:AGN), has a market cap of 101288.76, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 90.30%.
At the current price of 253.78, it has a dividend yield of *TBA, and its target price is 291.44. This is with a profit margin of *TBA, and total debt/equity of 0.59. Allergan plc (NYSE:AGN) has a P/E of *TBA, as well as a forward P/E of 14.49.
With a current EPS of -5.63, and a forecasted EPS growth for next year at 23.46%,Allergan plc (NYSE:AGN) has had a EPS growth for the past five years at -50.40%. For the next five years EPS growth is projected to be 10.80%.
Performance for the year is -24.71%. Since its IPO date on 2/17/1993, the total performance to date is -18.90%.
Volume today for Allergan plc (NYSE:AGN), is 1090874, while its average volume is 3558.32. Whilst the total gain today was 0.13%, it did have a day high of -2.87%.
Volatility for this week has been at 1.61%, and 1.81% for the month. The 52-week low for Allergan plc, AGN has been 29.81%, while the 52-week-high has reached -25.14%.
Looking at its return of investments, which is -1.30%, and its return on assets is *TBA. Allergan plc (NYSE:AGN) has an operating margin of *TBA. With a sales growth of -44.20% quarter over quarter. Bearing in mind that Allergan plc, AGN is in the sector Healthcare, its long-term debt/equity is 0.53, and has a current ratio of 1 and 0.9 for quick ratio.
So what is the value of Allergan plc? Well its PEG is *TBA, and the P/S is 6.21, along with a P/B of 1.38. Meanwhile it has a p/cash of 44.55.